CD69 and atherosclerosis: We have recently shown that CD69 expression on lymphocytes prevents atherosclerosis progression in mice and that low CD69 levels in PBLs predict subclinical atherosclerosis in asymptomatic individuals after adjustment for traditional cardiovascular risk factors (18).